beta
CUR
Neuralstem Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Neuralstem Inc is a biotechnology company. It is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.
Market Cap: 29.7 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.neuralstem.com
Shares Outstanding: 15.1 Million
Float: 12.1 Million
Dividend: 0.0 (0.0%)
Beta: 1.579865
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1423 trading days
From: 2014-04-09 To: 2019-10-30
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|---|---|---|---|---|---|
2017-01-09 | 13.0 | 1.0 | 13.0 |